Julie Mazenq

Dr. Julie Mazenq

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2017 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
JMJulie Mazenq
Julie Mazenq
JDJean-Christophe Dubus
Jean-Christophe Dubus
Jean GaudartJean Gaudart
Jean Gaudart
DCDenis Charpin
Denis Charpin
ANAntoine Nougairede
Antoine Nougairede
GNGuilhem Noel
Guilhem Noel
Children’s asthma is multifactorial. Environmental factors like air pollution exposure, meteorological conditions, allergens, and viral infections are strongly implicated. However, place of residence has rarely been investigated in connection with these factors. The primary aim of our study was to measure the impact of particulate matter (PM), assessed close to the children’s homes, on asthma-related pediatric emergency hospital visits within the Bouches-du-Rhône area in 2013. In a nested case-control study on 3- to 18-year-old children, each control was randomly matched on the emergency room visit day, regardless of hospital. Each asthmatic child was compared to 15 controls. PM10 and PM2.5, meteorological conditions, pollens, and viral data were linked to ZIP code and analyzed by purpose of emergency visit. A total of 68,897 visits were recorded in children, 1182 concerning asthma. Short-term exposure to PM10 measured near children’s homes was associated with excess risk of asthma emergency visits (adjusted odds ratio 1.02 (95% CI 1.01–1.04; p = 0.02)). Male gender, young age, and temperature were other risk factors. Conversely, wind speed was a protective factor.

30 November 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
MDMorgane Dervaux
Morgane Dervaux
CTCaroline Thumerelle
Caroline Thumerelle
CFCandice Fabre
Candice Fabre
RARola Abou-Taam
Rola Abou-Taam
TBTiphaine Bihouee
Tiphaine Bihouee
JDJean Christophe Dubus
Jean Christophe Dubus

1 November 2017 in Respiratory Medicine
Verified
Journal Article
Closed access
JMJulie Mazenq
Julie Mazenq
JDJean-Christophe Dubus
Jean-Christophe Dubus
Jean GaudartJean Gaudart
Jean Gaudart
DCDenis Charpin
Denis Charpin
GVGilles Viudes
Gilles Viudes
GNGuilhem Noel
Guilhem Noel

10 October 2023 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
KBKenza Rhzioual Berrada
Kenza Rhzioual Berrada
ABAlexandre Belot
Alexandre Belot
BNBénédicte Neven
Bénédicte Neven
COCamille Ohlmann
Camille Ohlmann
FTFrançois Tronc
François Tronc
PRPhilippe Reix
Philippe Reix

13 May 2024 in Paediatric Respiratory Reviews
Verified
Journal Article
Open access
JMJulie Mazenq
Julie Mazenq
JDJean-Christophe Dubus
Jean-Christophe Dubus
PCPascal Chanez
Pascal Chanez
DGDelphine Gras
Delphine Gras
Post infectious bronchiolitis obliterans (PIBO) is a rare but severe disease in children. Several respiratory pathogens are incriminated but adenovirus is still the most represented. Risk factors are well described: the male gender, hypoxemia at diagnosis and required mechanical ventilation. No risk factor is linked to the newborn period. The clinical spectrum of PIBO is broad, ranging from asymptomatic patients with fixed airflow obstruction to severe respiratory insufficiency requiring continuous oxygen supplementation. Diagnosis includes a combination of a clinical history, absence of reversible airflow obstructions and ground glass and gas trapping on high resolution computed tomography. PIBO is primarily a neutrophilic pathology of small bronchioles characterized by high levels of pro-inflammatory cytokines leading to tissue remodeling and fibrosis of the small airways. The difficulty is to discriminate between the host's normal response, an exaggerated inflammatory response and the potential iatrogenic consequences of the initial infection treatment, particularly prolonged mechanical ventilation. Damage to the respiratory epithelium with a possible link to viral infections are considered as potential mechanisms of PIBO. No specific management exists. Much remains to be done in this field to clarify the underlying mechanisms, identify biomarkers, and develop clear monitoring pathways and treatment protocols.

28 July 2020 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
PAPierre Alauzet
Pierre Alauzet
AMAurelie Morand
Aurelie Morand
JMJulie Mazenq
Julie Mazenq
Jean GaudartJean Gaudart
Jean Gaudart
EBEmmanuelle Bosdure
Emmanuelle Bosdure
JDJean Christophe Dubus
Jean Christophe Dubus